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IRON (FSO4) BIOAVAILABILITY IN OBESE SUBJECTS SUBMITTED TO 
BARIATRIC SURGERY 
Abstract 
Objective: To determine iron bioavailability in obese subjects after the ingestion 
of a nutritional supplement containing multiple nutrients.  
Methods: Fourteen persons were studied before and after bariatric surgery after 
the ingestion of a nutritional formulation containing 25 mg iron, 25 g fiber and 
800 mg calcium. Serum iron levels were measured basally and every hour after 
the ingestion of 200 mL of the formulation, and serum ferritin, unsaturated iron 
binding capacity (UIBC), hemoglobin, albumin, total proteins, total triglycerides, 
total cholesterol and fractions (LDL-cholesterol and HDL-cholesterol) sere 
determined at the same time points. 
Results: The following ferremia values (median and minimum - maximum) were 
obtained before and after bariatric surgery, respectively: Fasting, 105 (70 - 364) 
μg/dL and 198 (38 - 617) μg/dL; 1 hour, 103 (63 - 305) μg/dL and 160 (11 - 207) 
μg/dL; 2 hours, 103 (62 - 150) μg/dL and 141 (10 - 412) μg/dL; 3 hours. 97 (63 - 
190) μg/dL and 153 (6 - 270) μg/dL; 4 hours, 91 (58 - 163) μg/dL and 156 (40 - 
251) μg/dL (p>0.05), with no association of serum iron levels with time. There 
was a difference in total triglycerides (95 ± 29 mg/dL and 60 ± 10 mg/dL) which 
were correlated with a decrease in serum ferritin levels (r = 0,926, p = 0.008), 
UIBC (r = 0.910, p = 0.01), total cholesterol (r = 0,918, p = 0.01) and LDL-c 
fraction (r = 0.830, p = 0.04), with an increase in HDL-c fraction (r = 0,807, p = 
0.05).  
Conclusion: Iron bioavailability in obese subjects was affected by the ingestion 
of the nutritional formulation containing calcium and fiber and the serum ferritin 
and UIBC values involved in the body metabolism of iron were reduced by the 
surgery, a fact that may cause these patients to develop iron deficiency. 
Keywords: iron bioavailability, nutritional formulation, obese subjects, bariatric 
surgery 
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INTRODUCTION  
Iron bioavailability is defined by measuring the proportion of the total 
element offered by the oral route as part of the diet which is utilized for the 
maintenance of the normal functions of the organism including digestion and 
absorption. Iron absorption is influenced by the organic reserve and by the 
solubility of the element, which in turn is influenced by its valence and/or by the 
form of binding to other nutrients. Dietary factors tend to alter iron absorption as 
a function of the interactions among nutrients and proper absorption is 
important for the prevention and treatment of possible nutritional disorders1-2.  
Obese patients are characterized by a set of co-morbidities associated 
with the accumulation of adipose tissue, including the presence of iron-
deficiency anemia. In particular, iron deficiency is considered to be a severe 
disorder in patients submitted to bariatric surgery3-4. A possible factor triggering 
or precipitating iron deficiency is the interaction between the nutrients included 
in the formulation of the supplements offered to these patients5-6. Inadequate 
intake and intestinal malabsorption may also be considered to be a cause of 
iron deficiency, intimately related to the mechanical changes induced by 
bariatric surgery3-7. On this basis, it is imperative to study the mechanisms of 
iron absorption and regulation in these patients during the preoperative and 
postoperative periods.  
Thus, the objective of the present study was to assess iron bioavailability 
in obese patients after the ingestion of a nutritional supplement containing 
multiple nutrients before and six months after bariatric surgery. 
METHODOLOGY  
Patients 
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The study was conducted on14 obese individuals of both genders aged 
18 to 50 years, during the preoperative and postoperative period of bariatric 
surgery. Surgery was performed at the Center for the Treatment of Bariatric 
Surgery of the Discipline of Nutrology, University Hospital, Faculty of Medicine 
of Ribeirão Preto (HCFMRP). The study was approved by the Research Ethics 
Committee of the Hospital, and the data were collected from November 2007 to 
December 2008.   
Inclusion Criteria: Adult subjects aged 18 to 50 years with no diseases 
potentially interfering with absorptive capacity and giving informed consent to 
participate.  
Exclusion Criteria: Patients with anemia (hemoglobin level of less than 10.0 
mg/dL), with chronic renal insufficiency, alcoholism, intestinal parasitic 
diseases, diabetes, and chronic diarrhea were excluded from the study. 
Preparation  and Composition of the Nutritional Supplement Formulation 
The formulation was prepared at the Hospital Pharmacy of HCFMRP and 
placed in sealed pots containing 100 g powder. For use in the Metabolic Unit of 
HCFMRP, 100 g powder was diluted in 200 mL filtered water, transferred to a 
pot with a lid and stored in the refrigerator for 12 hours. The experimental 
assays involving the research subjects were started in the morning. The 
formulation of the nutritional supplement provided 25.0 mg elemental iron from 
hepta-hydrated ferrous sulfate, and its interaction with 800 mg calcium and 25 g 
fiber was determined. The formulation contained 38 additional nutrients, whose 
quality and quantity are listed in Tables 1 and 2. 
Experimental Procedure 
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The nutritional formulation was prepared on the day preceding the 
experiment using aseptic techniques and stored in a refrigerator for 12 hours 
before being offered to the research subjects. The experiments conducted  
before and six months after surgery were started in the morning and lasted 5 
hours. The volunteers were studied in the Metabolic Unit of HCFMRP, sitting on 
a reclining armchair. Water intake was permitted throughout the experiment. 
After an overnight fast of 12 hours, a blood sample was collected from each 
subject. Each patient then received the prepared multiple nutrient formulation 
containing 100 g powder in a final volume of 200 mL. Blood samples were 
obtained at 0, 1, 2, 3 and 4 hours8-9.  
Protocol for the Study of the Response Curve of Serum Iron 
For data comparison, the areas under the curve of ferremia concentration 
obtained from the five plasma concentrations (time 0 and 1, 2, 3 and 4 hours) 
and the sum of these values were calculated in addition to the difference 
between the concentrations obtained at each time point and at time 010. 
Biochemical Evaluation of the Patients 
Determination of Serum Iron Levels after the Ingestion of the Nutritional 
Supplement Formulation 
Serum samples were placed in demineralized Eppendorf tubes and stored 
frozen at -20oC until the time for analysis. Iron concentrations were determined 
by inductively coupled plasma mass spectrometry (ICP-MS) in the DRC mode 
according to the method of Palmer et al.,11 with the samples being diluted 1:20 
with 0.5%  HNO3 diluent (v/v) + 0.005% TRITON X-100(v/v). Readings were 
then obtained with a Perkin Elmer ELAN DRC PLUS instrument equipped with a 
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cyclonic chamber and coupled to a Meinhard nebulizer under conditions of 
optimization of gas flow of 0.60 mL/min, lens voltage of 6.00 A and 
radiofrequency power of 1100.00 W.  
 
Determination of Biochemical Indicators 
 The reference values adopted by HCFMRP for the laboratory tests 
studied are: serum iron, 35 to 150 μg/dL; ferritin,  28 to 397 ng/mL (men) and 6 
to 159 ng/mL (women); UIBC, 112 to 346 mg/dL; hemoglobin, 12 to 13 g/dL; 
albumin, 3 to 5.4 g/dL; total proteins, 6.4 to 8.2 g/dL; borderline range of total 
cholesterol, 200 to 239 mg/dL (lower: <200 mg/dL, increased: 240 mg/dL); 
desirable HDL cholesterol, 40 mg/dL; borderline range of LDL cholesterol, 130 
a 159 mg/dL (lower: <130 mg/dL, increased: 160 mg/dL); borderline range of 
triglycerides, 150 to 199 mg/dL (lower: <150 mg/dL, increased, 200 mg/dL)   
Statistical Analysis 
 Friedman’s ANOVA was used to analyze the data regarding iron 
absorption before and after surgery at time 0 and from 1 to 4 hours of the 
experiment. The parametric Student t-test for two groups was used to compare 
the areas under the curve of serum iron levels obtained before and after surgery 
and at the 4 time points compared to the basal time (fasting value, t = 0). The 
paired Student t-test for independent samples was used to compare the 
biochemical parameters of the patients determined before and six months after 
surgery. Statistical analysis was performed with the aid of the Statistics 6.0 
software (STATASOFT INC., Tulsa, OK)12. The level of significance was set at 
p < 0.05 in all analyses.  
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RESULTS  
Table 3 presents the serum iron levels of obese patients determined 
before and after bariatric surgery. The values are reported as median and range 
because the data did not present normal distribution. Table 4 presents the area 
under the serum curves for the obese patients before and after bariatric 
surgery. The Student t-test showed that there was a significant difference 
between the two times, revealing a greater mobilization of circulating iron after 
the surgery.  
Table 5 presents the pre- and postoperative values of the biochemical 
indicators of the patients, which were analyzed by the paired Student t-test. 
There was a difference in mean total triglyceride levels between times, with a 
significant reduction six months after the surgical procedure. Also, serum 
ferritin, UIBC, total cholesterol and LDL cholesterol levels were reduced after 
surgery, whereas HDL cholesterol was increased.   
DISCUSSION  
Regarding nutrient interactions, it is known that excess amounts of one 
nutrient can worsen or improve the absorption of another, as is the case, for 
example, for iron and zinc or iron and vitamin C3-5. In the present study, after 
the ingestion of a nutritional supplement containing multiple nutrients, the mean 
value of the area under the curve for serum iron differed in relation to the curve 
obtained before the surgical procedure. However, on both occasions, iron 
absorption was low, possibly demonstrating that iron absorption from 
supplements may be negatively affected by several nutrients such as calcium, 
fiber and perhaps others not studied here. In addition, this may suggest a 
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greater mobilization of body iron regarding the reduction of serum ferritin and 
UIBC after the surgical procedure.  
Cook, Dassenko and Whittaker13 assessed the effect of calcium salts 
commonly used as supplements on iron absorption when administered during 
the interval between meals and observed that calcium carbonate at the dose of 
600 mg did not inhibit the absorption of ferrous sulfate (18 mg), at an 
iron/calcium proportion of 1:33). When the same assays were repeated using 
citrate and phosphate salts as a source of calcium at the same concentrations, 
iron absorption was reduced to 44% and 62%, respectively, showing that the 
type of salts used can also affect the bioavailability of minerals. Reddy and 
Cook14 observed that different iron/calcium proportions (above 1:40) and the 
types of salt sources of the minerals interfere with the bioavailability of iron.  
Yoon et al.15 discussed the possibility of fiber acting on the human 
gastrointestinal tract by causing changes in the utilization of nutrients and 
showed that greater amounts of fiber (>20 g/day) can affect the bioavailability of 
minerals. The supplements studied here contained 25 g fiber that may have 
represented a factor capable of reducing iron absorption.  
Rosa3 observed an increase in ferremia in obese adults with the 
ingestion of 15 mg iron and zinc in the sulfate form before and after bariatric 
surgery, with no change in iron absorption at any time point (1, 2, 3 or 4 hours) 
compared to the basal concentration (time zero). The area under the curve did 
not differ between the preoperative and postoperative period. Brolin et al.16 
observed that 155 of 348 patients (47%) receiving vitamin and mineral 
supplements after bariatric surgery presented iron deficiency. Oral iron 
supplementation corrected iron deficiency in only 43% of them.  
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When monitoring patients before and after bariatric surgery, Vargas-Ruiz 
et al.17 observed that 6.6% of them were anemic before surgery and that iron 
deficiency was detected in 40.0% and 54.5% of them 2 and 3 years after 
surgery, respectively. Anemia was observed in 46.6% and 63.6% of the patients 
after 2 and 3 years, respectively. Love & Billett18 suggested that iron prophylaxis 
should be oral after bariatric surgery and should be associated with the 
presence of vitamin C. These patients also require lifelong monitoring of 
hematologic and iron parameters since iron deficiency and anemia may develop 
years after the surgery. When deficiency is detected and oral treatment is not 
sufficient, parenteral nutrition, blood transfusions or surgical interventions are 
necessary.  
Surgical treatment has shown increasing success in combating the 
disease; however, iron deficiency may occur due to the reduction of enzymatic 
secretions, changes in gastric acidity and intolerance of red meat intake. An 
important physiological factor is the exclusion of the duodenal region of the 
small intestine, which is responsible for iron absorption. It has also been shown 
that changes in taste and rejection of certain foods are associated with reduced 
gastric capacity. These two factors may result in multiple nutritional deficiencies 
involving iron, calcium, zinc, copper and vitamins of the B, A, and  D complex18-
19
.  
 
CONCLUSION 
 Iron availability in solutions containing multiple nutrients was impaired in 
obese patients both before and six months after bariatric surgery. Ferremia 
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levels were reduced after surgery, a fact that may cause these patients to 
develop iron deficiency. 
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Table 1 – Composition of the nutritional supplements administered to obese 
patients 
Components Formulation of the 
Nutritional Supplement 
Total Protein (g) 
Soy Protein Isolate 
 
3.1 
Total Carbohydrates (g) 
Maltodextrin 
 
64.1 
Fat (g) 
TCM 
Corn oil 
Canola Oil 
Soy Lectin 
 
 
1.0 
3.5 
0.3 
Minerals (g) 
 
Salt Mixture 
 
3.0 
 Vitamins (g) 
Vitamin Mixture 
 
1.0 
Fiber (g) 
Partially hydrolyzed guar gum 
 
25.0 
Total (g) 100.0 
 
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Table 2 – Composition of the salt mixture in the nutritional supplement formulation 
 
 
1Dilution: 3.0 g salt mixture/100 g supplement 
  Salts        Value in 
300 g 
                    of the salt 
mixture 
Element Quantity of the 
element in 300 g of 
the salt mixture 
Quantity of 
the element in 
1000 kg1 
Quantity of 
the element in 
200 g1 
FeSO4.7H20     6.80 g   
MgCO3             8.00 g 
KH2PO4          48.00 g 
 
ZnSO4.7H20   0.316 g 
KIO3                0.024 g 
MnSO4.H20     0.054 g 
CuSO4.5H20   0.046 g 
NaCl               24,00 g 
 
CaCO3          200.00 g 
Maltodextrin    12,76 g 
Iron 
Magnesium 
Phoshphorus 
Potassium 
Zinc 
Iodine 
Manganese 
Copper 
Sodium 
Chorine 
Calcium 
2500.00  mg 
2.29 g  
11.13 g 
14. 04 g  
72.00 mg 
14. 40 mg 
17. 64 mg 
11. 88 mg 
9. 22 g  
14. 24 g  
80.00 g 
250.00  mg 
115.00 mg 
557.00 mg 
702.00 mg 
3.60 mg 
0.72 mg 
0.88 mg 
0.59 mg 
461.00 mg 
712.00 mg 
8,00.00 mg 
50.0 mg 
28.75 mg 
139.25 mg 
175.5 mg 
0.9 mg 
0.18 mg 
0.22 mg 
0.15 mg 
115.25 mg 
178.00 mg 
1,00.00 mg 
Total                  300 g     
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Table 3 – Postoperative serum iron levels (g/dL) as a function of time of 
ingestion of formulations for obese patients 
 
 
 Preoperative  Postoperative 
Variable Median 
(range) 
Median 
(range) 
Fasting 105 (70 - 364) 198 (38 - 617) 
1 hour 103 (63 - 305) 160 (11 -207) 
2 hours 103 (62 - 150) 141 (10 - 412) 
3 hours 97 (63 - 190) 153 (6 - 270) 
4 hours 91 (58 - 163) 156 (40 - 250) 
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Table 4 – Values of the area under the curve for obese patients who ingested a 
formulation of nutritional supplementation before and after bariatric surgery 
 
 
Patient Preoperative 
Curve  
(g/dL/hour) 
Postoperative 
Curve  
(g/dL/hour) 
1 397.0 
           926 
 
2 380.0 641 
3 453.0 154 
4 327.0 1050 
5 908.0 180 
6 550.0 875 
7 260.0 228 
8 353.0  
Mean 
Standard Deviation 
P value (Student t-
test) 
 
453.50 
202.80 
6.32 
0.000 
579.00 
380.30 
3.96 
0.007 
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Table 5 – Biochemical indicators of obese patients before and six months after 
bariatric surgery 
 
*Statistically significant values (p  0.05) 
Biochemical 
indicators 
Preoperative 
value  
Mean (SD) 
 
Postoperative 
value 
Mean (SD) 
p Correlation 
(paired Student 
t-test) 
p 
Serum Iron, μg/dL 80 (25) 63 (14) 0.91 r = 0.647 0.16 
Ferritin, ng/mL 160 (105) 122 (78) 0.91 r = 0.926 *0.008 
UIBC, mg/dL 212 (65) 206 (49) 0.60 r = 0.910 *0.01 
Hemoglobin, g/dL 13 (1,5) 13 (1,7) 0.79 r = -0.699 0.12 
Albumin, g/dL 4 (0,2) 4 (0,2) 0.17 r = -0.208 0.69 
Total Proteins, g/dL 6 (0,4) 7 (0,2) 0.86 r = -0.080 0.88 
Cholesterol, mg/dL 173 (45) 153 (35) 0.52 r = 0.918 *0.01 
HDL, mg/dL 40 (12) 46 (11) 0.95 r = 0.807 *0.05 
LDL, mg/dL 114 (38) 96 (29) 0.91 r = 0.830 *0.04 
Triglycerides mg/dL 95 (29) 60 (10) *0.007 r = 0,768 0.07 
